Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
New and Emerging Drug Classes That Will Outlast the Pandemic
New and Emerging Drug Classes That Will Outlast the Pandemic
BioSpace
COVID-19
pandemic
drug discovery
AVCs
vaccines
DNA vaccines
Flag link:
Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?
Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?
Fierce Biotech
China
COVID-19
Gilead Sciences
remdesivir
Folotyn
Acrotech Biopharma
Flag link:
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
Pfizer Criticizes Sudden Change in Coronavirus Vaccine Dosing Regime in the U.K.
Motley Fool
Pfizer
BioNTech
vaccines
UK
BNT162b2
AstraZeneca
AZD1222
COVID-19
Flag link:
China’s Sinopharm Claims COVID-19 Vaccine has 79% Efficacy
China’s Sinopharm Claims COVID-19 Vaccine has 79% Efficacy
BioSpace
Sinopharm
China
COVID-19
vaccines
clinical trials
Flag link:
Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo
Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo
Yahoo/Reuters
Pfizer
BioNTech
COVID-19
vaccines
placebos
clinical trials
Flag link:
Operation Warp Speed Slow to Ramp Up COVID-19 Vaccine Distribution
Operation Warp Speed Slow to Ramp Up COVID-19 Vaccine Distribution
BioSpace
vaccines
pandemic
COVID-19
Operation Warp Speed
distribution
logistics
Flag link:
Moderna in talks with South Korea to supply 40 million doses of Covid-19 vaccine
Moderna in talks with South Korea to supply 40 million doses of Covid-19 vaccine
Pharmaceutical Business Review
Moderna Therapeutics
South Korea
COVID-19
vaccines
Flag link:
AstraZeneca's COVID-19 vaccine gets the green light in the UK
AstraZeneca's COVID-19 vaccine gets the green light in the UK
Biopharma Reporter
UK
COVID-19
vaccines
AstraZeneca
Flag link:
Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union
Pfizer and BioNTech Supplying 100 Million Additional Doses of Coronavirus Vaccine to European Union
Motley Fool
Europe
vaccine
COVID-19
Pfizer
BioNTech
Flag link:
U.S. Department of Defense Awards Moderna $1.97 Billion COVID-19 Vaccine Contract
U.S. Department of Defense Awards Moderna $1.97 Billion COVID-19 Vaccine Contract
BioSpace
Moderna Therapeutics
COVID-19
vaccines
government contracts
Department of Defense
Flag link:
Biden joins public health experts in expressing dismay as early days of COVID vaccine rollout in U.S. fall far short of expectations
Biden joins public health experts in expressing dismay as early days of COVID vaccine rollout in U.S. fall far short of expectations
Marketwatch
vaccines
distribution
COVID-19
Joe Biden
Flag link:
Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive results
Regeneron says it will continue trial of COVID antibody cocktail as latest data show positive results
Marketwatch
Regeneron
COVID-19
antibodies
Flag link:
UK expected to approve Oxford-AstraZeneca Covid vaccine this week
UK expected to approve Oxford-AstraZeneca Covid vaccine this week
CNBC
UK
vaccines
COVID-19
AstraZeneca
Flag link:
EU is asked to approve extra dose from Pfizer vaccine vials
EU is asked to approve extra dose from Pfizer vaccine vials
Yahoo/Reuters
Europe
COVID-19
vaccines
Pfizer
BioNTech
Flag link:
Novavax Starts a Late-Stage Coronavirus Vaccine Clinical Trial
Novavax Starts a Late-Stage Coronavirus Vaccine Clinical Trial
Motley Fool
Novavax
vaccines
COVID-19
clinical trials
Flag link:
Why New Coronavirus Strains Could Boost Pfizer and Moderna's Fortunes
Why New Coronavirus Strains Could Boost Pfizer and Moderna's Fortunes
Motley Fool
vaccines
COVID-19
UK
Pfizer
Moderna Therapeutics
Flag link:
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
What if we captured the spirit and urgency of Covid-19 research to cure cancer?
MedCity News
COVID-19
R&D
drug development
cancer
oncology
Flag link:
Moderna or Pfizer? Which Company Stands to Gain the Most From Vaccine Rollout
Moderna or Pfizer? Which Company Stands to Gain the Most From Vaccine Rollout
Motley Fool
Moderna Therapeutics
Pfizer
BioNTech
COVID-19
vaccines
Flag link:
Therapeutics for ‘COVID-19 Long-Haulers’ Exploding onto the Scene as 2020 Ends
Therapeutics for ‘COVID-19 Long-Haulers’ Exploding onto the Scene as 2020 Ends
BioSpace
PureTech Health
COVID-19
COVID long-haulers
Long COVID
Flag link:
Merck signs $356M deal to supply US with experimental coronavirus drug
Merck signs $356M deal to supply US with experimental coronavirus drug
BioPharma Dive
Merck
COVID-19
government contract
Flag link:
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »